436
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability

, , &
Pages 559-569 | Received 17 Oct 2014, Accepted 15 Jun 2015, Published online: 04 Aug 2015

References

  • Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech, 2009;10(1):211–19
  • Aungst BJ, Nguyen NH, Rogers NJ, Rowe SM, Hussain MA, White SJ, Shum L. Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses. Int J Pharm, 1997;156:79–88
  • Barrett AM, Dehghani F, Foster NR. Increasing the dissolution rate of itraconazole processed by gas antisolvent techniques using polyethylene glycol as a carrier. Pharm Res, 2008;25(6):1274–89
  • Beule KD, Gestel JV. Pharmacology of Itraconazole. Drugs, 2001;61(1):27–37
  • Beule KD. Itraconazole: Pharmacology, clinical experience and future development. Int J Antimicrob Ageing, 1996;6:175–81
  • Bouchemal K, Briançon S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimisation. Int J Pharm, 2004;280(1–2):241–51
  • Burcham DL, Maurin MB, Hausner EA, Huang SM. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm Drug Dispos, 1997;18(8):737–42
  • Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today, 2011;16(7–8):354–60
  • Craig DQM, Lievens HSR, Pitt KG, Storey DE. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int J Pharm, 1993;96:147–55
  • Fernandez-Campos F, Clares Naveros B, Lopez Serrano O, Alonso Merino C, Calpena Campmany AC. Evaluation of novel nystatin nanoemulsion for skin candidosis infections. Mycoses, 2013;56(1):70–81
  • Fryd MM, Mason TG. Advanced nanoemulsions. Annu Rev Phys Chem, 2012;63:493–518
  • Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer, 2001;37:1590–8
  • Hong JY, Kim JK, Song YK, Park JS, Kim CK. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release, 2006;110(2):332–8
  • Hu J, Johnston KP, Williams RO III. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm, 2004;30(3):233–45
  • Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm, 1999;1987:209–18
  • Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 2004;274(1–2):65–73
  • Kim JK, Park JS, Kim CK. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm, 2010;383(1–2):209–15
  • Koteswari P, Krishna SR, Reddy VP, Narasu LM. Formulation and preparation of felodipine nanoemulsions. Asian J Pharm Clin Res, 2011;4:116–17
  • Kotta S, Khan AW, Pramod K, Ansari SH, Sharma RK, Ali J. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv, 2012;9(5):585–98
  • Miyake K, Irie T, Arima H, Hirayama F, Uekama K, Hiramo M, Okamoto Y. Characterization of itraconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int J Pharm, 1999;179:237–45
  • Momoh AO, Oladunmoye MK, Adebolu TT. Evaluation of the antimicrobial and phytochemical properties of oil from castor seeds (Ricinus communis Linn). Bull Environ Pharmacol Life Sci, 2012;1(10):21–7
  • Murakami A, Fukada K, Yamano Y, Gohtani S. Effects of sugars on the D phase emulsification of triglyceride using polyoxyethylene sorbitan fatty acid ester. J Oleo Sci, 2005;54(12):633–9
  • Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: A systematic review. Crit Care, 2011;15(6):R287
  • Myers RA, Stella VJ. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm, 1992;78:217–26
  • Narkhede RS, Gujar KN, Gambhire VM. Design and evaluation of self-nanoemulsifying drug delivery systems for nebivolol hydrochloride. Asian J Pharm, 2014;8(3):200–9
  • Palin KJ, Phillips AJ, Ning A. The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm, 1986;33:99–104
  • Rangel-Yagui CO, Pessoa-Jr A, Tavare LC. Micellar solubilization of drugs. J Pharm Pharma Sci 2005;8(2):147–63
  • Rasenack N, Müller BW. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm Res, 2002;19(12):1894–900
  • Ravi TPU, Padma T. Nanoemulsions for drug delivery through different routes. Res Biotechnol, 2011;2(3):1–13
  • Rigter IM, Schipper HG, Koopmans RP, Van Kan HJM, Frijlink HW, Kager PA, Guchelaar HJ. Relatively bioavailability of three newly developed albendazole formulations: A randomized cross over study with healthy volunteers. Antimicrob Agents Chemother, 2004;48:1051–4
  • Saag MS, Dismukes WE. Azole antifungal agents: Emphasis on new triazoles. Antimicrob Agents Chemother, 1988;32(1):1–8
  • Serajuddin ATM, Sheen PC, Mufson D, Bernstein DF, Augusti MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci, 1988;77(5):414–17
  • Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm, 1994;106:15–23
  • Singh N. Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis, 2001;33:1692–6
  • Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res, 2004;21(2):201–30
  • Tang SY, Shridharan P, Sivakumar M. Impact of process parameters in the generation of novel aspirin nanoemulsions – Comparative studies between ultrasound cavitation and microfluidizer. Ultrason Sonochem, 2013;20(1):485–97
  • Tao T, Zhao Y, Wu J, Zhou B. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. Int J Pharm, 2009;367(1–2):109–14
  • Uchegbu IF, Schatzlein AG, Cheng WP, Lalatsa A. 2013. Fundamentals of pharmaceutical science. New York: Springer Publications
  • Wakerly MG, Pouton CW, Meakin BJ, Morton FS. Self-emulsification of vegetable oil-nonionic surfactant mixtures. ACS Symp Ser, 1986;311:242–55
  • Walsh TJ, Dixon DM. 1996. Spectrum of mycoses. In: Baron S, ed. Medical microbiology. NCBI Bookshelf. Bethesda, MD: A Service of the National Library of Medicine, National Institutes of Health. [Online] Available at: http://www.ncbi.nlm.nih.gov/books/NBK7902/?report=printable
  • Wisplinghoff H, Bischoff T, Edmond MB, Tallent SM, Seifert H, Wenzel RP. Nosocomial bloodstream infections in US Hospitals: Analysis of 24,179 cases from a Prospective Nationwide Surveillance Study. Clin Infect Dis, 2004;39:309–17
  • Woo JS, Song YK, Hong JY, Lim SJ, Kim CK. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci, 2008;33(2):159–65

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.